In this study, we show that TrkC was highly expressed in metastatic breast cancer and that TrkC may contribute to the conversion of breast cancer cells into a more aggressive and chemoresistant form via acquirement of mesenchymal characteristics and metastatic ability. Here, NTRK3 is linked to breast carcinoma.